✦ LIBER ✦

Autopsy-confirmed progressive supranuclear palsy with decreased uptake of metaiodobenzylguanidine

✍ Scribed by Adachi, Tadashi; Kitayama, Michio; Wada-Isoe, Kenji; Nakano, Toshiya; Nakashima, Kenji

Book ID: 122994323
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 472 KB
Volume: 115
Category: Article
ISSN: 0303-8467
DOI: 10.1016/j.clineuro.2013.01.004

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rates of cerebral atrophy in autopsy-con

Rates of cerebral atrophy in autopsy-confirmed progressive supranuclear palsy

✍ Keith A. Josephs; Jennifer L. Whitwell; Bradley F. Boeve; Maria M. Shiung; Jeffr 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 707 KB

Apraxia of eyelid closure in autopsy-con

Apraxia of eyelid closure in autopsy-confirmed vascular progressive supranuclear palsy

✍ Silvia Favaretto; Sergio Ferrari; Leontino Battistin; Annachiara Cagnin 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 263 KB

Progressive supranuclear palsy presentin

Progressive supranuclear palsy presenting with primary progressive aphasia—Clinicopathological report of an autopsy case

✍ A. Mochizuki; Y. Ueda; Y. Komatsuzaki; K. Tsuchiya; T. Arai; S. Shoji 📂 Article 📅 2003 🏛 Springer-Verlag 🌐 English ⚖ 628 KB

Decreased β-amyloid peptide42 in cerebro

Decreased β-amyloid peptide42 in cerebrospinal fluid of patients with progressive supranuclear palsy and corticobasal degeneration

✍ Moeko Noguchi; Mitsuhiro Yoshita; Yasuko Matsumoto; Kenjiro Ono; Kazuo Iwasa; Ma 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Decrease of serotonin-S2 receptors in te

Decrease of serotonin-S2 receptors in temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy

✍ Dr. J. M. Maloteaux; E. C. Laterre; P. M. Laduron; F. Javoy-Agid; Y. Agid 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 544 KB

The number of serotonin-S, receptors was decreased in the temporal cortex of patients with Parkinson's disease and progressive supranuclear palsy (PSP). There was no significant modification of these receptors in the frontal cortex or in the hippocampus and putamen in both diseases. The decrease in